1. Home
  2. DHI vs ILMN Comparison

DHI vs ILMN Comparison

Compare DHI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D.R. Horton Inc.

DHI

D.R. Horton Inc.

N/A

Current Price

$137.06

Market Cap

38.6B

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$265.72

Market Cap

37.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DHI
ILMN
Founded
1978
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.6B
37.0B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
DHI
ILMN
Price
$137.06
$265.72
Analyst Decision
Hold
Buy
Analyst Count
18
21
Target Price
$159.83
★ $202.65
AVG Volume (30 Days)
2.2M
★ 2.3M
Earning Date
10-29-2026
10-29-2026
Dividend Yield
★ 1.32%
N/A
EPS Growth
N/A
★ 170.87
EPS
★ 7.45
2.22
Revenue
★ $34,250,400,000.00
$4,343,000,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
$5.13
$6.40
P/E Ratio
★ $18.86
$123.85
Revenue Growth
N/A
★ N/A
52 Week Low
$131.75
$88.00
52 Week High
$176.22
$278.99

Technical Indicators

Market Signals
Indicator
DHI
ILMN
Relative Strength Index (RSI) 37.33 73.86
Support Level $133.16 $116.43
Resistance Level $153.01 N/A
Average True Range (ATR) 3.26 12.31
MACD -0.18 3.27
Stochastic Oscillator 0.00 90.76

Price Performance

Historical Comparison
DHI
ILMN

About DHI D.R. Horton Inc.

D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: